Q4 ResultsAs long as I've followed this company, I seem to always mis-judge market reaction to the quarters.
Personally, I felt the quarter was superb and all the reasons why I'm invested in this company.
Diluted EPS 62% higher, FCFA2S higher by 59%, 68% for the year, and acquisitions broadly back to pre-COVID levels and that excludes the Topicus purchase that falls into the new year.
Perfect.